$PHAT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Phathom Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Phathom Pharmaceuticals, Inc.. Get notifications about new insider transactions in Phathom Pharmaceuticals, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 29 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.08 | 370 | 12,980 | 882,240 | 882.6 K to 882.2 K (-0.04 %) |
Jun 29 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 36.07 | 1,250 | 45,088 | 882,610 | 883.9 K to 882.6 K (-0.14 %) |
Jun 29 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.46 | 22,881 | 811,360 | 883,860 | 906.7 K to 883.9 K (-2.52 %) |
Jun 09 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.00 | 100 | 3,500 | 942,005 | 942.1 K to 942 K (-0.01 %) |
Jun 09 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.05 | 2,264 | 79,353 | 942,105 | 944.4 K to 942.1 K (-0.24 %) |
May 26 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 36.59 | 548 | 20,051 | 989,596 | 990.1 K to 989.6 K (-0.06 %) |
May 26 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 36.16 | 10,399 | 376,028 | 990,144 | 1 M to 990.1 K (-1.04 %) |
May 26 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 36.10 | 1,683 | 60,756 | 1,000,543 | 1 M to 1 M (-0.17 %) |
May 26 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.58 | 8,911 | 317,053 | 1,002,226 | 1 M to 1 M (-0.88 %) |
May 24 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Option Exercise | A | 35.49 | 12,500 | 443,625 | 12,500 | |
May 24 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.74 | 11,648 | 416,300 | 1,011,137 | 1 M to 1 M (-1.14 %) |
May 24 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.10 | 7,098 | 249,140 | 1,022,785 | 1 M to 1 M (-0.69 %) |
May 18 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.00 | 100 | 3,500 | 1,029,883 | 1 M to 1 M (-0.01 %) |
May 14 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.33 | 100 | 3,533 | 1,029,983 | 1 M to 1 M (-0.01 %) |
May 14 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 36.06 | 905 | 32,634 | 1,030,083 | 1 M to 1 M (-0.09 %) |
May 14 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.39 | 10,871 | 384,725 | 1,030,988 | 1 M to 1 M (-1.04 %) |
May 07 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.01 | 202 | 7,072 | 1,042,870 | 1 M to 1 M (-0.02 %) |
May 07 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.14 | 6,936 | 243,731 | 1,043,072 | 1.1 M to 1 M (-0.66 %) |
May 05 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 38.53 | 100 | 3,853 | 1,050,008 | 1.1 M to 1.1 M (-0.01 %) |
May 05 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 37.47 | 3,500 | 131,145 | 1,050,108 | 1.1 M to 1.1 M (-0.33 %) |
May 05 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 36.21 | 4,690 | 169,825 | 1,053,608 | 1.1 M to 1.1 M (-0.44 %) |
May 05 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 35.50 | 11,070 | 392,985 | 1,058,298 | 1.1 M to 1.1 M (-1.04 %) |
May 05 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 39.06 | 203 | 7,929 | 1,069,368 | 1.1 M to 1.1 M (-0.02 %) |
May 05 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 38.45 | 11,272 | 433,408 | 1,069,571 | 1.1 M to 1.1 M (-1.04 %) |
May 05 2021 | PHAT | Phathom Pharmaceut ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Sell | S | 37.60 | 3,157 | 118,703 | 1,080,843 | 1.1 M to 1.1 M (-0.29 %) |
May 04 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 37.86 | 1,089 | 41,231 | 765,700 | 766.8 K to 765.7 K (-0.14 %) |
May 04 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 37.09 | 1,400 | 51,921 | 766,789 | 768.2 K to 766.8 K (-0.18 %) |
May 04 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 36.15 | 1,968 | 71,150 | 768,189 | 770.2 K to 768.2 K (-0.26 %) |
May 04 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 38.59 | 5,753 | 221,994 | 770,157 | 775.9 K to 770.2 K (-0.74 %) |
May 04 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 37.85 | 4,290 | 162,360 | 775,910 | 780.2 K to 775.9 K (-0.55 %) |
Apr 07 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 38.03 | 6,795 | 258,415 | 1,340,945 | 1.3 M to 1.3 M (-0.50 %) |
Apr 07 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 37.37 | 6,328 | 236,501 | 1,347,740 | 1.4 M to 1.3 M (-0.47 %) |
Apr 07 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 35.97 | 3,359 | 120,823 | 1,354,068 | 1.4 M to 1.4 M (-0.25 %) |
Apr 07 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 34.96 | 1,400 | 48,945 | 1,357,427 | 1.4 M to 1.4 M (-0.10 %) |
Apr 07 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 37.15 | 1,730 | 64,275 | 1,358,827 | 1.4 M to 1.4 M (-0.13 %) |
Apr 07 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 36.40 | 7,769 | 282,793 | 1,360,557 | 1.4 M to 1.4 M (-0.57 %) |
Apr 07 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 35.69 | 12,619 | 450,337 | 1,368,326 | 1.4 M to 1.4 M (-0.91 %) |
Apr 05 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 37.11 | 785 | 29,134 | 780,200 | 781 K to 780.2 K (-0.10 %) |
Apr 05 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 36.37 | 4,316 | 156,954 | 780,985 | 785.3 K to 781 K (-0.55 %) |
Apr 05 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 35.66 | 4,252 | 151,645 | 785,301 | 789.6 K to 785.3 K (-0.54 %) |
Apr 05 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 38.14 | 1,742 | 66,442 | 789,553 | 791.3 K to 789.6 K (-0.22 %) |
Apr 05 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 37.28 | 3,405 | 126,927 | 791,295 | 794.7 K to 791.3 K (-0.43 %) |
Mar 23 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Option Exercise | M | 6.95 | 11,513 | 80,015 | 855,687 | |
Mar 23 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Sell | S | 44.08 | 1,140 | 50,256 | 0 | 1.1 K to 0 (-100.00 %) |
Mar 23 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Sell | S | 43.24 | 10,373 | 448,495 | 1,140 | 11.5 K to 1.1 K (-90.10 %) |
Mar 23 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Buy | M | 6.95 | 11,513 | 80,015 | 11,513 | 0 to 11.5 K |
Mar 15 2021 | PHAT | Phathom Pharmaceut ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | S | 43.75 | 710,000 | 31,062,500 | 3,115,008 | 3.8 M to 3.1 M (-18.56 %) |
Mar 12 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 46.67 | 500 | 23,335 | 1,380,945 | 1.4 M to 1.4 M (-0.04 %) |
Mar 12 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 47.54 | 731 | 34,749 | 1,381,445 | 1.4 M to 1.4 M (-0.05 %) |
Mar 12 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 47.18 | 41,698 | 1,967,349 | 1,382,176 | 1.4 M to 1.4 M (-2.93 %) |
Mar 12 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 49.93 | 1,802 | 89,974 | 1,423,874 | 1.4 M to 1.4 M (-0.13 %) |
Mar 12 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 49.02 | 7,844 | 384,515 | 1,425,676 | 1.4 M to 1.4 M (-0.55 %) |
Mar 12 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 48.32 | 2,425 | 117,167 | 1,433,520 | 1.4 M to 1.4 M (-0.17 %) |
Mar 03 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 46.23 | 2,070 | 95,695 | 794,700 | 796.8 K to 794.7 K (-0.26 %) |
Mar 03 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 45.17 | 1,600 | 72,276 | 796,770 | 798.4 K to 796.8 K (-0.20 %) |
Mar 03 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 46.73 | 24 | 1,122 | 798,370 | 798.4 K to 798.4 K (0.00 %) |
Mar 03 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 46.16 | 4,833 | 223,080 | 798,394 | 803.2 K to 798.4 K (-0.60 %) |
Mar 03 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 44.60 | 600 | 26,757 | 803,227 | 803.8 K to 803.2 K (-0.07 %) |
Mar 03 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 46.05 | 1,548 | 71,293 | 803,827 | 805.4 K to 803.8 K (-0.19 %) |
Mar 03 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 45.77 | 3,825 | 175,069 | 805,375 | 809.2 K to 805.4 K (-0.47 %) |
Jan 29 2021 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Option Exercise | A | 39.11 | 150,000 | 5,866,500 | 150,000 | |
Jan 29 2021 | PHAT | Phathom Pharmaceut ... | Branning Todd P. | Chief Financial Off ... | Option Exercise | A | 39.11 | 60,000 | 2,346,600 | 60,000 | |
Jan 29 2021 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Option Exercise | A | 39.11 | 225,000 | 8,799,750 | 225,000 | |
Jan 13 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 36.18 | 20,091 | 726,983 | 1,532,945 | 1.6 M to 1.5 M (-1.29 %) |
Jan 13 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 35.74 | 7,074 | 252,812 | 1,553,036 | 1.6 M to 1.6 M (-0.45 %) |
Jan 13 2021 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 34.92 | 12,835 | 448,243 | 1,560,110 | 1.6 M to 1.6 M (-0.82 %) |
Dec 18 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 42.00 | 100 | 4,200 | 1,572,945 | 1.6 M to 1.6 M (-0.01 %) |
Dec 18 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 41.43 | 12,915 | 535,071 | 1,573,045 | 1.6 M to 1.6 M (-0.81 %) |
Dec 18 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 40.49 | 35,197 | 1,425,105 | 1,585,960 | 1.6 M to 1.6 M (-2.17 %) |
Dec 18 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 48.99 | 200 | 9,798 | 1,621,157 | 1.6 M to 1.6 M (-0.01 %) |
Dec 18 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 48.19 | 12,954 | 624,253 | 1,621,357 | 1.6 M to 1.6 M (-0.79 %) |
Dec 18 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 47.35 | 13,292 | 629,366 | 1,634,311 | 1.6 M to 1.6 M (-0.81 %) |
Dec 18 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 46.22 | 5,000 | 231,103 | 1,647,603 | 1.7 M to 1.6 M (-0.30 %) |
Nov 12 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 40.36 | 903 | 36,446 | 1,652,603 | 1.7 M to 1.7 M (-0.05 %) |
Nov 12 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 39.22 | 3,354 | 131,557 | 1,653,506 | 1.7 M to 1.7 M (-0.20 %) |
Nov 12 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 38.17 | 2,620 | 100,018 | 1,656,860 | 1.7 M to 1.7 M (-0.16 %) |
Nov 12 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 43.07 | 200 | 8,614 | 1,659,480 | 1.7 M to 1.7 M (-0.01 %) |
Nov 12 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 42.31 | 4,601 | 194,675 | 1,664,081 | 1.7 M to 1.7 M (-0.28 %) |
Nov 12 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 41.29 | 7,880 | 325,383 | 1,668,682 | 1.7 M to 1.7 M (-0.47 %) |
Nov 12 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 44.00 | 100 | 4,400 | 1,676,562 | 1.7 M to 1.7 M (-0.01 %) |
Nov 12 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 42.67 | 5,477 | 233,683 | 1,676,662 | 1.7 M to 1.7 M (-0.33 %) |
Nov 12 2020 | PHAT | Phathom Pharmaceut ... | Socks David A | Director | Sell | S | 41.95 | 5,207 | 218,422 | 1,682,139 | 1.7 M to 1.7 M (-0.31 %) |
Nov 03 2020 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Sell | S | 36.83 | 14,500 | 534,026 | 852,700 | 867.2 K to 852.7 K (-1.67 %) |
Nov 03 2020 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Gift | G | 0.00 | 867,200 | 0 | 867,200 | 0 to 867.2 K |
Nov 03 2020 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Gift | G | 0.00 | 867,200 | 0 | 0 | 867.2 K to 0 (-100.00 %) |
Jul 13 2020 | PHAT | Phathom Pharmaceut ... | Branning Todd P. | Chief Financial Off ... | Option Exercise | A | 29.43 | 85,000 | 2,501,550 | 85,000 | |
Jul 02 2020 | PHAT | Phathom Pharmaceut ... | Nabulsi Azmi | Chief Operating Off ... | Option Exercise | A | 32.20 | 70,000 | 2,254,000 | 70,000 | |
Jul 02 2020 | PHAT | Phathom Pharmaceut ... | Curran Terrie | President and Chief ... | Option Exercise | A | 32.20 | 175,000 | 5,635,000 | 175,000 | |
Jun 16 2020 | PHAT | Phathom Pharmaceut ... | Frazier Life Sciences IX, L.P. | 10% Owner | Sell | J | 0.00 | 1,456,854 | 0 | 5,827,415 | 7.3 M to 5.8 M (-20.00 %) |
May 22 2020 | PHAT | Phathom Pharmaceut ... | Yamada Tadataka | Director | Option Exercise | A | 36.85 | 10,000 | 368,500 | 10,000 | |
May 22 2020 | PHAT | Phathom Pharmaceut ... | Topper James N | Director | Option Exercise | A | 36.85 | 10,000 | 368,500 | 10,000 | |
May 22 2020 | PHAT | Phathom Pharmaceut ... | FIELDS HEIDI | Director | Option Exercise | A | 36.85 | 10,000 | 368,500 | 10,000 | |
May 22 2020 | PHAT | Phathom Pharmaceut ... | COLA MICHAEL F | Director | Option Exercise | A | 36.85 | 10,000 | 368,500 | 10,000 | |
Mar 31 2020 | PHAT | Phathom Pharmaceut ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 24.55 | 30,600 | 751,264 | 3,707,408 | 3.7 M to 3.7 M (+0.83 %) |
Mar 31 2020 | PHAT | Phathom Pharmaceut ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 24.60 | 30,000 | 738,000 | 3,676,808 | 3.6 M to 3.7 M (+0.82 %) |
Mar 19 2020 | PHAT | Phathom Pharmaceut ... | Stenhouse Mark | Director | Option Exercise | A | 29.84 | 20,000 | 596,800 | 20,000 | |
Oct 30 2019 | PHAT | Phathom Pharmaceut ... | Edwards Jonathan S. | Director | Buy | P | 19.00 | 24,426 | 464,094 | 47,984 | 23.6 K to 48 K (+103.68 %) |
Oct 30 2019 | PHAT | Phathom Pharmaceut ... | Edwards Jonathan S. | Director | Buy | P | 19.00 | 1,028,205 | 19,535,895 | 2,019,877 | 991.7 K to 2 M (+103.68 %) |
Oct 30 2019 | PHAT | Phathom Pharmaceut ... | Edwards Jonathan S. | Director | Buy | C | 15.20 | 23,558 | 358,082 | 23,558 | 0 to 23.6 K |
Oct 30 2019 | PHAT | Phathom Pharmaceut ... | Edwards Jonathan S. | Director | Buy | C | 15.20 | 991,672 | 15,073,414 | 991,672 | 0 to 991.7 K |
Oct 30 2019 | PHAT | Phathom Pharmaceut ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | P | 19.00 | 1,052,631 | 19,999,989 | 7,284,269 | 6.2 M to 7.3 M (+16.89 %) |
Oct 30 2019 | PHAT | Phathom Pharmaceut ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | C | 15.20 | 1,353,640 | 20,575,328 | 6,231,638 | 4.9 M to 6.2 M (+27.75 %) |
Page: 1